Evidence map›Paper›PMID 38673530›Full record

ArticleJournal of clinical medicine2024

Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis.

Fabian Aus dem Siepen, Selina Hein, Eva Hofmann, Christian Nagel, Stéphanie K Schwarting, Ute Hegenbart, Stefan O Schönland, Markus Weiler, Norbert Frey, Arnt V Kristen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Fabian Aus dem SiepenDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Selina HeinDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.ORCID 0000-0003-0139-4200
Eva HofmannDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Christian NagelDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Stéphanie K SchwartingDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Ute HegenbartDepartment of Hematology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0003-1917-6746
Stefan O SchönlandDepartment of Hematology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-4853-5579
Markus WeilerDepartment of Neurology, University Hospital Heidelberg, 69120 Heidelberg, Germany.ORCID 0000-0002-8942-7662
Norbert FreyDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Arnt V KristenDepartment of Cardiology, Angiology and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amyloidosisATTRheart failure therapytransthyretin

Identifiers

PMID38673530
PMCPMC11051169
OpenAlexW4394798582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.